Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
| 47.91 | |
| 50.38 | |
| - | |
| 49.79 | |
| 47.35 | |
| 44.6653-57.0608 | |
| 53 792 M | |
| 28.9699 | |
| 1 119 M | |
| 22 090 M | |
| 0.4193 | |
| 0.0191 | |
| 0.703 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
It is hard to get excited after looking at Siemens Healthineers' (ETR:SHL) recent performance, when its stock has declined 5.2% over the past three months. But if you pay close attention, you might ga...
Siemens Healthineers (ETR:SHL) Third Quarter 2024 Results Key Financial Results Revenue: €5.42b (up 4.3% from 3Q 2023). Net income: €469.0m (up 5.4% from 3Q 2023). Profit margin: 8.6% (in line w...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
